This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.

A recent article in the journal Nature Communications describes the structural basis of mimicked HBV/HDV viral peptide drug interaction with its receptor NTCP. HBV, an enveloped DNA virus ...

The replication of the Nipah virus's genetic material in infected cells has been demonstrated for the first time by researchers from the Max Planck Institute (MPI) for Multidisciplinary Sciences and ...

Two key advances in the 1980s — genome sequencing and structure-based drug design ... Importantly, for HCV, combination of antiviral drugs with immunomodulatory interferons may eradicate ...

Antiviral drug development is now progressing at the pace antibiotics were 30 years ago. At present, there are some 60 antiviral drug preparations that have been approved by the US FDA ...

Dr. Hauke Hillen was able to visualize the three-dimensional structure of the viral "copying machine". These findings could contribute to the future development of antiviral drugs for the treatment of ...

What strides have scientists made in developing vaccines and antiviral drugs to treat and protect people from dengue infections? Vaccines are an important way to protect people from viral infections.

Antiviral drugs can be used for the treatment of influenza and the prevention of seasonal and post-exposure influenza. Four antiviral drugs are available for the prevention and treatment of ...

Cocrystal Pharma (NASDAQ:COCP – Get Free Report) is expected to release its earnings data before the market opens on Thursday, March 27th. Analysts expect Cocrystal Pharma to post earnings of ($0.55) ...